Recon: WHO adopts pandemic treaty, US unveils most-favored-nation pricing targets

• RFK Jr. declared war on chronic disease. First comes the battle over priorities (STAT)
• US health authorities set most-favored-nation pricing targets (Reuters)
• Is Your UTI Pain Reliever Safe and Effective? (Bloomberg)
• IDEA ranks Lilly, AZ as biopharma's top innovators, inventors (Fierce Pharma)

• With U.S. absent, WHO adopts pandemic treaty aimed at improving vaccine access (STAT)
• Robert F. Kennedy Jr calls WHO 'moribund', urges others to quit (Reuters)
• WHO says vaccine-derived poliovirus detected in Papua New Guinea (Reuters)
• MORE Details On MHRA’s Online Platform For Post Market Surveillance (MedTech Insight)

• Tourmaline drug cuts inflammation tied to heart disease (STAT)
• Why sunblock in the U.S. is so much worse than in the E.U. (STAT)
• Trump’s science adviser calls for return to ‘gold-standard’ research to kickstart stalled advances (STAT)
• Pfizer joins PD-1xVEGF race with $1.25B upfront to Chinese biotech 3SBio (Endpoints)
• Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in funds (Endpoints)
• Exclusive: Weight loss startup Calibrate swaps CEOs in latest leadership shakeup (Endpoints)
• Exclusive: Optura raises $6.5M to help evaluate healthcare AI programs (Endpoints)
• Why Regeneron is buying 23andMe (Endpoints)
• Stelara biosimilars look to gain traction, helped by recent lessons from Humira (Endpoints)
• Boehringer Ingelheim’s late-stage data for lung disease candidate underwhelm some analysts (Endpoints)
• Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff (Endpoints)
• Weight-loss company Noom pivots to smaller doses of compounded Wegovy (Reuters)

• Exclusive: At-home screening startup Reperio Health raises $14M (Endpoints)
• Teal posts data on newly approved at-home cancer screening device (MedTech Dive)
• Women’s health faces growing headwinds, despite jump in venture investment (MedTech Dive)
•  For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst (Fierce Pharma)

• I study diet and chronic illness. Here’s the uncomfortable truth about seed oils (STAT)
• RFK Jr. calls for healthier school meals as Trump cancels program that funded them (Reuters)
• Common Fish Food Poisoning Types and Prevention Methods (Food Safety)
• CDC Provides Insights on 2023-2024 Salmonella Outbreak Linked to Charcuterie-Style Meats (Food Safety)

• The Man Who Built UnitedHealth Into an Industry Giant Now Has to Turn It Around (Bloomberg)
• Texas Isn’t Declaring a Measles Victory Yet (Bloomberg)
• Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders (FDA Law Blog)
• When the FDA requires a large vaccine trial, who pays? (STAT)